or
forgot password
  • cancer clinical trials in rochester, MN

  • Percutaneous Cryoablation in Treating Patients With Painful Bone Metastases
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Metastatic Cancer, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer
    Mayo Clinic
    Rochester, Minnesota 55905
    Anaplastic Thyroid Cancer, Recurrent Thyroid Cancer, Stage III Follicular Thyroid Cancer, Stage III Papillary Thyroid Cancer, Stage IV Follicular Thyroid Cancer, Stage IVA Follicular Thyroid Cancer, Stage IVA Papillary Thyroid Cancer, Stage IVB Follicular Thyroid Cancer, Stage IVB Papillary Thyroid Cancer, Stage IVC Follicular Thyroid Cancer, Stage IVC Papillary Thyroid Cancer, Thyroid Gland Medullary Carcinoma
    Family Study of Lymphoproliferative Disorders
    Mayo Clinic
    Rochester, Minnesota 55905
    Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Monoclonal B-Cell Lymphocytosis, Multiple Myeloma
    Vibro-Acoustography Imaging in Diagnosing Breast Masses in Women With a Breast Mass or Breast Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Breast Cancer
    Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study
    Rochester Methodist Hospital, Mayo Clinic
    Rochester, Minnesota 55905
    Hepatic Veno-Occlusive Disease
    Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
    Mayo Clinic
    Rochester, Minnesota 55905
    Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Recurrent Adult Acute Myeloid Leukemia
    Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
    Mayo Clinic
    Rochester, Minnesota 55905
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Viral Therapy in Treating Patients With Metastatic Melanoma
    Mayo Clinic
    Rochester, Minnesota 55905
    Recurrent Melanoma, Stage IV Melanoma
    Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer
    Mayo Clinic
    Rochester, Minnesota 55905
    Anal Cancer, Carcinoma of the Appendix, Colorectal Cancer, Esophageal Cancer, Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Gastric Cancer, Gastrointestinal Carcinoid Tumor, Gastrointestinal Stromal Tumor, Liver Cancer, Pancreatic Cancer, Small Intestine Cancer
    Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors
    Mayo Clinic
    Rochester, Minnesota 55905
    Extra-adrenal Paraganglioma, Gastrointestinal Carcinoid Tumor, Head and Neck Cancer, Islet Cell Tumor, Kidney Cancer, Lung Cancer, Melanoma (Skin), Neuroendocrine Carcinoma of the Skin, Pheochromocytoma, Unspecified Adult Solid Tumor, Protocol Specific
    Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma
    Mayo Clinic
    Rochester, Minnesota 55905
    Melanoma (Skin)
    Combination Chemotherapy in Treating Patients With Sarcoma
    Mayo Clinic
    Rochester, Minnesota 55905
    Ovarian Cancer, Sarcoma
    Dasatinib and Lapatinib in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By Surgery
    Mayo Clinic
    Rochester, Minnesota 55905
    Unspecified Adult Solid Tumor, Protocol Specific
    Prospective Observational Epidemiologic Study of Maraviroc's Safety
    Pfizer Investigational Site
    Rochester, Minnesota 55905
    Human Immunodeficiency Virus
    Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline
    Mayo Clinic
    Rochester, Minnesota 55905
    Breast Cancer, Depression, Hot Flashes, Psychosocial Effects of Cancer and Its Treatment
    CC-4047 in Treating Patients With Myelofibrosis
    Mayo Clinic
    Rochester, Minnesota 55905
    Chronic Myeloproliferative Disorders, Secondary Myelofibrosis
    A Phase 1 Study of BMS-833923 (XL139) in Subjects With Advanced or Metastatic Cancer
    Mayo Clinic Rochester
    Rochester, Minnesota 55905
    Hedgehog Pathway, Smoothened, Basal Cell Carcinoma (BCC), Basal Cell Nevoid Syndrome (BCNS)
    Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Kidney Cancer, Leukemia, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer
    Pfizer Investigational Site
    Rochester, Minnesota 55905
    Kidney Neoplasms
    Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
    Mayo Clinic
    Rochester, Minnesota 55905
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
    Mayo Clinic
    Rochester, Minnesota 55905
    Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer
    Mayo Clinic
    Rochester, Minnesota 55905
    Thyroid Cancer
    Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Liver Cancer, Neuroblastoma, Ototoxicity, Ovarian Cancer, Sarcoma
    Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer
    Mayo Clinic

    Trial Locations
    Mayo Clinic
    University of Southern California
    Ovarian Neoplasms
    Obatoclax and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
    Mayo Clinic
    Rochester, Minnesota 55905
    Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Mayo Clinic
    Rochester, Minnesota 55905
    Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    A Long-Term Study of the Effects of Orally Administered SAR302503 in Patients With Myelofibrosis
    Mayo Clinic, Rochester
    Rochester, Minnesota 55905
    Myelofibrosis
    Multiple Ascending Dose (MDX1105-01)
    Mayo Clinic
    Rochester, Minnesota 55905
    Cancer, Multiple Indications
    Saracatinib in Treating Patients With Previously Treated Metastatic Pancreatic Cancer
    Mayo Clinic
    Rochester, Minnesota 55905
    Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer
    Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
    Mayo Clinic
    Rochester, Minnesota 55905
    Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Angioimmunoblastic T-cell Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, Essential Thrombocythemia, Extramedullary Plasmacytoma, Intraocular Lymphoma, Isolated Plasmacytoma of Bone, Juvenile Myelomonocytic Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Mast Cell Leukemia, Meningeal Chronic Myelogenous Leukemia, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Primary Myelofibrosis, Primary Systemic Amyloidosis, Progressive Hairy Cell Leukemia, Initial Treatment, Prolymphocytic Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Stage 0 Chronic Lymphocytic Leukemia, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Small Noncleaved Cell Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Hodgkin Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Childhood Small Noncleaved Cell Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Childhood Small Noncleaved Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Hodgkin Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Small Noncleaved Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, T-cell Large Granular Lymphocyte Leukemia, Unspecified Childhood Solid Tumor, Protocol Specific, Untreated Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies, Untreated Hairy Cell Leukemia, Waldenström Macroglobulinemia
    Pemetrexed or Erlotinib as Second-Line Therapy in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Mayo Clinic
    Rochester, Minnesota 55905
    Recurrent Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Phase II Study of Oral Panobinostat in Adult Patients With Relapsed/Refractory Classical Hodgkin's Lymphoma
    Mayo Clinic - Rochester Hematology
    Rochester, Minnesota 55905
    Classical Hodgkin's Lymphoma (i.e. Nodular Sclerosing, Mixed-cellularity, Lymphocyte-rich, Lymphocyte-depleted)
    Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors
    Mayo Clinic
    Rochester, Minnesota 55905
    Non-Small Cell Lung Cancer, Prostate Cancer, Pancreatic Cancer
    Stereotactic Body Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Lung Cancer
    Efficacy and Safety Study of OncoVEXGM-CSF Compared to GM-CSF in Melanoma
    Mayo Clinic
    Rochester, Minnesota 55905
    Melanoma
    Neuropsychological and Behavioral Testing in Young Patients With Cancer
    Mayo Clinic
    Rochester, Minnesota 55905
    Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Unspecified Childhood Solid Tumor, Protocol Specific
    Lenalidomide With or Without Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
    Mayo Clinic
    Rochester, Minnesota 55905
    Multiple Myeloma and Plasma Cell Neoplasm
    Inositol in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia
    Mayo Clinic
    Rochester, Minnesota 55905
    Non-small Cell Lung Cancer, Squamous Lung Dysplasia
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Mayo Clinic
    Rochester, Minnesota 55905
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    A Study of Nilotinib Versus Imatinib in GIST Patients
    Mayo Clinic - Rochester Division of Hematology
    Rochester, Minnesota 55905
    Gastrointestinal Stromal Tumor (GIST)
    S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Extrahepatic Bile Duct Cancer, Gallbladder Cancer
    Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction
    Mayo Clinic
    Rochester, Minnesota 55905
    Multiple Myeloma, Plasma Cell Neoplasm
    Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
    Mayo Clinic
    Rochester, Minnesota 55905
    Adult Acute Lymphoblastic Leukemia in Remission, B-cell Adult Acute Lymphoblastic Leukemia, L1 Adult Acute Lymphoblastic Leukemia, L2 Adult Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia, T-cell Adult Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia
    Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
    Mayo Clinic
    Rochester, Minnesota 55905
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
    Mayo Clinic
    Rochester, Minnesota 55905
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IV Colon Cancer, Stage IV Rectal Cancer